Current and Investigational Drug Strategies for Glioblastoma

M Ajaz; S Jefferies; L Brazil; C Watts; A Chalmers

doi:10.1016/j.clon.2014.03.012

Back

Journal article

Current and Investigational Drug Strategies for Glioblastoma

M Ajaz, S Jefferies, L Brazil, C Watts and A Chalmers

CLINICAL ONCOLOGY, Vol.26(7), pp.419-430

01/07/2014

DOI: https://doi.org/10.1016/j.clon.2014.03.012

Abstract

Science & Technology

Life Sciences & Biomedicine

Oncology

ONCOLOGY

Chemotherapy

clinical trials

glioblastoma multiforme

new agents

RECURRENT MALIGNANT GLIOMA

HIGH-GRADE GLIOMA

PHASE-II TRIAL

NEWLY-DIAGNOSED GLIOBLASTOMA

DOSE-INTENSE TEMOZOLOMIDE

BRAIN-TUMOR CONSORTIUM

BEVACIZUMAB PLUS IRINOTECAN

INTEGRATED GENOMIC ANALYSIS

TYROSINE KINASE INHIBITORS

ENDOTHELIAL GROWTH-FACTOR

Files and links (1)

url

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000339273900007&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11d2a86992e85fb529977dad66a846d5View

Author

Metrics

24 Record Views

27 Times Cited - Web of Science

Details

Title: Current and Investigational Drug Strategies for Glioblastoma
Creators: M Ajaz
S Jefferies
L Brazil
C Watts
A Chalmers
Publication Details: CLINICAL ONCOLOGY, Vol.26(7), pp.419-430
Publisher: ELSEVIER SCIENCE LONDON
Date published: 01/07/2014
Date submitted: 26/07/2016
Identifiers: 99513630702346
Academic Unit: University of Surrey
Language: English
Resource Type: Journal article

Current and Investigational Drug Strategies for Glioblastoma

Abstract

Files and links (1)

Metrics

Details

Usage Policy